N Masuda Selected Research

N Masuda Research Topics

Disease

25	Breast Neoplasms (Breast Cancer) 01/2019 - 05/2000
10	Neoplasms (Cancer) 07/2016 - 02/2000
7	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2017 - 02/2000
6	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2017 - 07/2000
6	Esophageal Squamous Cell Carcinoma 11/2008 - 05/2000
4	Neutropenia 01/2017 - 07/2000
4	Neoplasm Metastasis (Metastasis) 07/2016 - 05/2000
4	Lymphatic Metastasis 10/2004 - 09/2000
4	Esophageal Neoplasms (Esophageal Cancer) 09/2001 - 01/2000
2	Hypoxia (Hypoxemia) 11/2008 - 03/2008
2	Lung Neoplasms (Lung Cancer) 09/2001 - 01/2001
2	Carcinogenesis 05/2000 - 01/2000
1	Anemia 01/2019
1	Triple Negative Breast Neoplasms 04/2017
1	Leukopenia 01/2017
1	Febrile Neutropenia 01/2017
1	Colonic Neoplasms (Colon Cancer) 12/2012
1	Hand-Foot Syndrome 11/2011
1	Erythema 11/2011
1	Disease Progression 12/2010
1	Nausea 11/2009
1	Vomiting 11/2009
1	Systemic Inflammatory Response Syndrome (Sepsis Syndrome) 04/2006
1	Carcinoma (Carcinomatosis) 10/2004
1	Infections 11/2002
1	Drug-Related Side Effects and Adverse Reactions 01/2001
1	Pathologic Constriction (Stenosis) 01/2001

Drug/Important Bio-Agent (IBA)

7	Docetaxel (Taxotere)FDA Link 01/2017 - 08/2000
7	Irinotecan (Camptosar)FDA LinkGeneric 02/2009 - 07/2000
4	Hormones (Hormone)IBA 07/2018 - 01/2010
4	Cyclophosphamide (Cytoxan)FDA LinkGeneric 08/2014 - 10/2005
3	Fluorouracil (Carac)FDA LinkGeneric 08/2014 - 10/2005
3	Epirubicin (Ellence)FDA LinkGeneric 08/2014 - 10/2005
3	Proteins (Proteins, Gene)FDA Link 07/2003 - 01/2000
2	Lapatinib (GW572016)FDA Link 07/2018 - 11/2017
2	Paclitaxel (Taxol)FDA LinkGeneric 07/2018 - 08/2014
2	Trastuzumab (Herceptin)FDA Link 07/2018 - 05/2014
2	Fulvestrant (Faslodex)FDA Link 06/2017 - 12/2010
2	Estrogen ReceptorsIBA 04/2015 - 12/2010
2	Biomarkers (Surrogate Marker)IBA 04/2015 - 11/2013
2	Capecitabine (Xeloda)FDA Link 08/2014 - 11/2013
2	Phenobarbital (Luminal)FDA Link 07/2012 - 01/2001
2	Anastrozole (Arimidex)FDA LinkGeneric 08/2011 - 01/2010
2	Tamoxifen FDA LinkGeneric 08/2011 - 01/2010
2	exemestane (Aromasin)FDA Link 08/2011 - 01/2010
2	Cisplatin (Platino)FDA LinkGeneric 02/2003 - 01/2001
2	Telomerase (Telomerase Reverse Transcriptase)IBA 09/2001 - 05/2000
2	NitrogenIBA 09/2001 - 05/2000
2	3-nitrotyrosineIBA 09/2001 - 05/2000
2	Carboplatin (JM8)FDA LinkGeneric 07/2001 - 02/2000
2	Etoposide (VP 16)FDA LinkGeneric 07/2001 - 07/2000
2	Carcinoembryonic AntigenIBA 11/2000 - 05/2000
1	olaparibIBA 01/2019
1	human ERBB2 proteinIBA 01/2019
1	Bevacizumab (Avastin)FDA Link 04/2017
1	amrubicinIBA 01/2017
1	Tn antigenIBA 12/2012
1	Glycoproteins (Glycoprotein)IBA 12/2012
1	Monoclonal AntibodiesIBA 12/2012
1	IGF Type 1 Receptor (IGF 1 Receptor)IBA 12/2012
1	taxaneIBA 06/2012
1	eribulin FDA Link 06/2012
1	LipidsIBA 08/2011
1	Aromatase InhibitorsIBA 01/2010
1	Palonosetron (Aloxi)FDA Link 11/2009
1	Dexamethasone (Maxidex)FDA LinkGeneric 11/2009
1	Doxorubicin (Adriamycin)FDA LinkGeneric 07/2009
1	7-ethyl-10-hydroxycamptothecin beta-glucuronideIBA 02/2009
1	Carbonic Anhydrase IXIBA 11/2008
1	Aminophylline (Carine)FDA LinkGeneric 03/2008
1	SteroidsIBA 04/2006
1	Secretory Leukocyte Peptidase InhibitorIBA 04/2006
1	Protease Inhibitors (Protease Inhibitor)IBA 04/2006
1	Methylprednisolone FDA LinkGeneric 04/2006
1	Tissue Inhibitor of Metalloproteinase-3IBA 10/2004
1	Matrix Metalloproteinases (MMPs)IBA 10/2004
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 02/2003
1	Clarithromycin (Biaxin)FDA LinkGeneric 11/2002
1	Omeprazole (Prilosec)FDA LinkGeneric 11/2002
1	Amoxicillin (Wymox)FDA LinkGeneric 11/2002
1	ORALIT (ORS)IBA 06/2001
1	Cilostazol (Pletal)FDA LinkGeneric 01/2001
1	Topoisomerase I InhibitorsIBA 01/2001
1	Ticlopidine (Ticlid)FDA LinkGeneric 01/2001
1	Complement System Proteins (Complement)IBA 11/2000
1	Formaldehyde (Formol)FDA Link 11/2000
1	ParaffinIBA 11/2000
1	Kangai-1 Protein (Kangai 1 Protein)IBA 09/2000

Therapy/Procedure

12	Drug Therapy (Chemotherapy) 01/2019 - 01/2001
9	Therapeutics 07/2018 - 07/2000
4	Neoadjuvant Therapy 07/2018 - 07/2012
3	Segmental Mastectomy (Lumpectomy) 07/2016 - 04/2015
2	Mastectomy (Mammectomy) 07/2016 - 04/2016
2	Operative Surgical Procedures 07/2016 - 04/2016
2	Radiotherapy 11/2008 - 02/2000
2	Combination Drug Therapy (Combination Chemotherapy) 02/2003 - 08/2001
1	Time-to-Treatment 06/2017
1	Adjuvant Chemotherapy 04/2017
1	Premedication 11/2011
1	Lymph Node Excision (Lymph Node Dissection) 06/2001